PCSK9, apolipoprotein e and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism

Journal of Hepatology

Volumn 62, Issue 4, 2015, Pages 763-770

  Bridge, Simon H ^a,b   Sheridan, David A ^a,c   Felmlee, Daniel J ^a,d   Crossey, Mary M E ^e   Fenwick, Fiona I ^a   Lanyon, Clare V ^b   Dubuc, Geneviève ^f,h   Seidah, Nabil G ^f,h   Davignon, Jean ^f,h   Thomas, Howard C ^e   Taylor Robinson, Simon D ^e   Toms, Geoffrey L ^a   Neely, R Dermot G ^a,g   Bassendine, Margaret F ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NORTHUMBRIA UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF PLYMOUTH   (United Kingdom)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e ST MARY S HOSPITAL   (United Kingdom)

^f CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^g ROYAL VICTORIA INFIRMARY   (United Kingdom)

^h UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Apolipoprotein A1; Apolipoprotein E; HCV lipoviral particles; HDL C; Low density lipoprotein receptor; PCSK9

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN E; CD81 ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PEGINTERFERON ALPHA; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9; PROTEIN; RIBAVIRIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VIRUS RNA; LOW DENSITY LIPOPROTEIN; PCSK9 PROTEIN, HUMAN; SERINE PROTEINASE;

ADULT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 3; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD; CHRONIC HEPATITIS C; GENETICS; HEPACIVIRUS; LIVER CELL; METABOLISM; MIDDLE AGED; STATISTICS; VIRION; VIROLOGY;

ADULT; APOLIPOPROTEINS E; CHOLESTEROL, LDL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PROPROTEIN CONVERTASES; RECEPTORS, LDL; RNA, VIRAL; SERINE ENDOPEPTIDASES; STATISTICS AS TOPIC; VIRION;

EID: 84926421076     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.11.016     Document Type: Article

References (52)

1. K.N. Ly, J. Xing, R.M. Klevens, R.B. Jiles, J.W. Ward, and S.D. Holmberg The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007 Ann Intern Med 156 2012 271 278
2. N. Goossens, and F. Negro Is genotype 3 of the hepatitis C virus the new villain? Hepatology 59 2014 2403 2412
3. F. Negro, and A. Alberti The global health burden of hepatitis C virus infection Liver Int 31 2011 1 3
4. J. McCombs, T. Matsuda, I. Tonnu-Mihara, S. Saab, P. Hines, and G. L'Italien The risk of long-term morbidity and mortality in patients with chronic hepatitis C: results from an analysis of data from a Department of Veterans Affairs Clinical Registry JAMA Intern Med 174 2014 204 212
5. E.B. Tapper, and N.H. Afdhal Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3 J Viral Hepat 20 2013 669 677
6. M.F. Bassendine, D.A. Sheridan, S.H. Bridge, D.J. Felmlee, and R.D. Neely Lipids and HCV Semin Immunopathol 35 2013 87 100
7. D.J. Felmlee, M.L. Hafirassou, M. Lefevre, T.F. Baumert, and C. Schuster Hepatitis C virus, cholesterol and lipoproteins - impact for the viral life cycle and pathogenesis of liver disease Viruses 5 2013 1292 1324
8. K.E. Corey, E. Kane, C. Munroe, L.L. Barlow, H. Zheng, and R.T. Chung Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up Hepatology 50 2009 1030 1037
9. P. Podevin, A. Carpentier, V. Pene, L. Aoudjehane, M. Carriere, and S. Zaidi Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes Gastroenterology 139 2010 1355 1364
10. R. Bartenschlager, F. Penin, V. Lohmann, and P. Andre Assembly of infectious hepatitis C virus particles Trends Microbiol 19 2011 95 103
11. S.U. Nielsen, M.F. Bassendine, A.D. Burt, C. Martin, W. Pumeechockchai, and G.L. Toms Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients J Virol 80 2006 2418 2428
12. J.C. Meunier, R.S. Russell, R.E. Engle, K.N. Faulk, R.H. Purcell, and S.U. Emerson Apolipoprotein c1 association with hepatitis C virus J Virol 82 2008 9647 9656
13. K.S. Chang, J. Jiang, Z. Cai, and G. Luo Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture J Virol 81 2007 13783 13793
14. P. Gastaminza, K.A. Dryden, B. Boyd, M.R. Wood, M. Law, and M. Yeager Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture J Virol 84 2010 10999 11009
15. A. Merz, G. Long, M.S. Hiet, B. Brugger, P. Chlanda, and P. Andre Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome J Biol Chem 286 2011 3018 3032
16. M.T. Catanese, K. Uryu, M. Kopp, T.J. Edwards, L. Andrus, and W.J. Rice Ultrastructural analysis of hepatitis C virus particles Proc Natl Acad Sci U S A 110 2013 9505 9510
17. Q. Shi, J. Jiang, and G. Luo Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes J Virol 87 2013 6866 6875
18. B.D. Lindenbach, and C.M. Rice The ins and outs of hepatitis C virus entry and assembly Nat Rev Microbiol 11 2013 688 700
19. D.M. Owen, H. Huang, J. Ye, and M. Gale Jr. Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor Virology 394 2009 99 108
20. J. Jiang, X. Wu, H. Tang, and G. Luo Apolipoprotein e mediates attachment of clinical hepatitis C virus to hepatocytes by binding to cell surface heparan sulfate proteoglycan receptors PLoS ONE 8 2013 e67982
21. J. Zhang, G. Randall, A. Higginbottom, P. Monk, C.M. Rice, and J.A. McKeating CD81 is required for hepatitis C virus glycoprotein-mediated viral infection J Virol 78 2004 1448 1455
22. N.G. Seidah, Z. Awan, M. Chretien, and M. Mbikay PCSK9: a key modulator of cardiovascular health Circ Res 114 2014 1022 1036
23. P. Labonte, S. Begley, C. Guevin, M.C. Asselin, N. Nassoury, and G. Mayer PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression Hepatology 50 2009 17 24
24. W.E. Alborn, G. Cao, H.E. Careskey, Y.W. Qian, D.R. Subramaniam, and J. Davies Serum proprotein convertase subtilisin kexin type 9 is correlated directly with serum LDL cholesterol Clin Chem 53 2007 1814 1819
25. G. Dubuc, M. Tremblay, G. Pare, H. Jacques, J. Hamelin, and S. Benjannet A new method for measurement of total plasma PCSK9: clinical applications J Lipid Res 51 2010 140 149
26. S.H. Bridge, D.A. Sheridan, D.J. Felmlee, S.U. Nielsen, H.C. Thomas, and S.D. Taylor-Robinson Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection Gut 60 2011 680 687
27. D.A. Sheridan, S.H. Bridge, D.J. Felmlee, M.M. Crossey, H.C. Thomas, and S.D. Taylor-Robinson Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: evidence for an association with interferon sensitivity J Hepatol 57 2012 32 38
28. P. Roingeard Hepatitis C virus diversity and hepatic steatosis J Viral Hepat 20 2013 77 84
29. T. Cai, J.F. Dufour, B. Muellhaupt, T. Gerlach, M. Heim, and D. Moradpour Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis J Hepatol 55 2011 529 535
30. A. Rojas, J.A. Del Campo, M. Maraver, R. Aparcero, M. Garcia-Valdecasas, and M. Diago Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro J Viral Hepat 21 2014 19 24
31. D.A. Sheridan, S.H. Bridge, M.M. Crossey, D.J. Felmlee, F.I. Fenwick, and H.C. Thomas Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial Liver Int 34 2014 737 747
32. D.J. Felmlee, D.A. Sheridan, S.H. Bridge, S.U. Nielsen, R.W. Milne, and C.J. Packard Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particles Gastroenterology 139 2010 1774 1783
33. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
34. K.G. Alberti, P. Zimmet, J. Shaw Group IDFETFC The metabolic syndrome - a new worldwide definition Lancet 366 2005 1059 1062
35. R.C. Hollingsworth, P. Sillekens, P. van Deursen, K.R. Neal, and W.L. Irving Serum HCV RNA levels assessed by quantitative NASBA: stability of viral load over time, and lack of correlation with liver disease. The Trent HCV Study Group J Hepatol 25 1996 301 306
36. L. Uccellini, F.C. Tseng, A. Monaco, F.M. Shebl, R. Pfeiffer, and M. Dotrang HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations Hepatology 56 2012 86 94
37. G. Leandro, A. Mangia, J. Hui, P. Fabris, L. Rubbia-Brandt, and G. Colloredo Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data Gastroenterology 130 2006 1636 1642
38. L. Serfaty, T. Andreani, P. Giral, N. Carbonell, O. Chazouilleres, and R. Poupon Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C J Hepatol 34 2001 428 434
39. L.E. Adinolfi, M. Gambardella, A. Andreana, M.F. Tripodi, R. Utili, and G. Ruggiero Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity Hepatology 33 2001 1358 1364
40. S.R. Shah, K. Patel, P. Marcellin, G.R. Foster, M. Manns, and S. Kottilil Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3 Clin Gastroenterol Hepatol 9 2011 688 693
41. D.A. Sheridan, R.D. Neely, and M.F. Bassendine Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs) Clin Res Hepatol Gastroenterol 37 2013 10 16
42. P. Andre, F. Komurian-Pradel, S. Deforges, M. Perret, J.L. Berland, and M. Sodoyer Characterization of low- and very-low-density hepatitis C virus RNA-containing particles J Virol 76 2002 6919 6928
43. M.E. Haas, A.D. Attie, and S.B. Biddinger The regulation of ApoB metabolism by insulin Trends Endocrinol Metab 24 2013 391 397
44. S.H. Choi, and H.N. Ginsberg Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance Trends Endocrinol Metab 22 2011 353 363
45. S.G. Lakoski, T.A. Lagace, J.C. Cohen, J.D. Horton, and H.H. Hobbs Genetic and metabolic determinants of plasma PCSK9 levels J Clin Endocrinol Metab 94 2009 2537 2543
46. J.D. Horton, J.C. Cohen, and H.H. Hobbs PCSK9: a convertase that coordinates LDL catabolism J Lipid Res 50 2009 S172 S177
47. D.C. Chan, G. Lambert, P.H. Barrett, K.A. Rye, E.M. Ooi, and G.F. Watts Plasma proprotein convertase subtilisin/kexin type 9: a marker of LDL apolipoprotein B-100 catabolism? Clin Chem 55 2009 2049 2052
48. G. Perlemuter, A. Sabile, P. Letteron, G. Vona, A. Topilco, and Y. Chretien Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis FASEB J 16 2002 185 194
49. T. Selic Kurincic, G. Lesnicar, M. Poljak, J. Meglic Volkar, M. Rajter, and J. Prah Impact of added fluvastatin to standard-of-care treatment on sustained virological response in naive chronic hepatitis C Patients infected with genotypes 1 and 3 Intervirology 57 2014 23 30
50. M.F. Bassendine, D.A. Sheridan, D.J. Felmlee, S.H. Bridge, G.L. Toms, and R.D. Neely HCV and the hepatic lipid pathway as a potential treatment target J Hepatol 55 2011 1428 1440
51. M. Friedrich-Rust, M.F. Ong, S. Martens, C. Sarrazin, J. Bojunga, and S. Zeuzem Performance of transient elastography for the staging of liver fibrosis: a meta-analysis Gastroenterology 134 2008 960 974
52. M. Ziol, A. Handra-Luca, A. Kettaneh, C. Christidis, F. Mal, and F. Kazemi Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C Hepatology 41 2005 48 54